Compare LAB & CHMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LAB | CHMG |
|---|---|---|
| Founded | 1999 | 1833 |
| Country | United States | United States |
| Employees | 389 | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Major Banks |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 394.3M | 322.1M |
| IPO Year | 2008 | 1995 |
| Metric | LAB | CHMG |
|---|---|---|
| Price | $0.99 | $66.17 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 2 |
| Target Price | $1.35 | ★ $57.00 |
| AVG Volume (30 Days) | ★ 2.2M | 16.9K |
| Earning Date | 05-05-2026 | 04-17-2026 |
| Dividend Yield | N/A | ★ 2.04% |
| EPS Growth | ★ 61.54 | N/A |
| EPS | 0.33 | ★ 1.91 |
| Revenue | ★ $101,937,000.00 | N/A |
| Revenue This Year | N/A | $37.32 |
| Revenue Next Year | $2.63 | $9.13 |
| P/E Ratio | ★ $2.99 | $34.25 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.87 | $45.55 |
| 52 Week High | $1.72 | $70.83 |
| Indicator | LAB | CHMG |
|---|---|---|
| Relative Strength Index (RSI) | 54.90 | 55.33 |
| Support Level | $0.92 | $50.96 |
| Resistance Level | $1.02 | $70.41 |
| Average True Range (ATR) | 0.05 | 2.34 |
| MACD | 0.01 | -0.57 |
| Stochastic Oscillator | 72.33 | 23.40 |
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.
Chemung Financial Corp is a bank holding firm. Through its subsidiaries, the company provides various financial services, including demand, savings, and time deposits, commercial, residential, and consumer loans, letters of credit, wealth management services, employee benefit plans, insurance products, mutual funds, and brokerage services, among others. The company's reportable segments are Core Banking, Wealth Management (WMG) services, and Holding company and CFS. Maximum revenue is generated from the Core Banking segment, which derives revenue by attracting deposits from the general public and using such funds to originate different types of loans, and to invest in securities. The Wealth Management (WMG) services segment provides trust and investment advisory services to clients.